Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chadha

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Fertility and Sterility|March 1, 1989
Endometriosis: treatment with gonadotropin-releasing hormone agonist BuserelinA M Franssen, F M Kauer, D R Chadha, et al.
Biological Psychiatry|April 12, 2005
Familial and sporadic subtypes of early-onset Obsessive-Compulsive disorderGregory L Hanna, Daniel J Fischer, Kristin R Chadha, et al.
Journal of Clinical Pharmacology|May 1, 1975
Intense surveillance of adverse drug reactions. An analysis of 338 patientsB J Vakil, R D Kulkarni, N L Chabria, et al.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Fertility and Sterility|March 1, 1989
Endometriosis: treatment with gonadotropin-releasing hormone agonist BuserelinA M Franssen, F M Kauer, D R Chadha, et al.
Biological Psychiatry|April 12, 2005
Familial and sporadic subtypes of early-onset Obsessive-Compulsive disorderGregory L Hanna, Daniel J Fischer, Kristin R Chadha, et al.
Journal of Clinical Pharmacology|May 1, 1975
Intense surveillance of adverse drug reactions. An analysis of 338 patientsB J Vakil, R D Kulkarni, N L Chabria, et al.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Pageof 7